Altos Labs

/
Institutes of Science

Robin Franklin, PhD

Principal Investigator

Principal Investigator

Robin Franklin, PhD

"The reason I have joined Altos is to have the freedom to be able to tackle the big questions of cell health and aging critical to resolving some of the major challenges of medicine in a focused, collaborative and, I hope, ultimately successful fashion."

Dr. Robin Franklin is a Principal Investigator at the Altos Labs Cambridge Institute of Science.

Robin was previously Professor of Stem Cell Medicine at the Wellcome-MRC Cambridge Stem Cell Institute at the University of Cambridge. His laboratory has made many pioneering discoveries on the mechanisms by which adult CNS progenitors replace lost oligodendrocytes, describing how their function declines with aging and how this can be reversed, by, for example, partial reprogramming and manipulation of physical properties of the niche. Robin's laboratory studies the underlying mechanisms of adult somatic stem cell aging. He is an honorary Professor in the School of Biology, University of Cambridge and is a Fellow of both the Academy of Medical Sciences and the Royal Society. He was the recipient of the 2017 Barancik International Prize for Research Innovation and the 2021 King Faisal Prize for Medicine.

Robin was previously Professor of Stem Cell Medicine at the Wellcome-MRC Cambridge Stem Cell Institute at the University of Cambridge. His laboratory has made many pioneering discoveries on the mechanisms by which adult CNS progenitors replace lost oligodendrocytes, describing how their function declines with aging and how this can be reversed, by, for example, partial reprogramming and manipulation of physical properties of the niche. Robin's laboratory studies the underlying mechanisms of adult somatic stem cell aging. He is an honorary Professor in the School of Biology, University of Cambridge and is a Fellow of both the Academy of Medical Sciences and the Royal Society. He was the recipient of the 2017 Barancik International Prize for Research Innovation and the 2021 King Faisal Prize for Medicine.

Robin Franklin, PhD

"The reason I have joined Altos is to have the freedom to be able to tackle the big questions of cell health and aging critical to resolving some of the major challenges of medicine in a focused, collaborative and, I hope, ultimately successful fashion."